Clinical trial
Phase Ib/II Clinical Trial of Topical Verapamil Hydrochloride for Chronic Rhinosinusitis With Nasal Polyps
NCT03102190 is registered in ClinicalTrials.gov with Benjamin Bleier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase Ib/II Clinical Trial of Topical Verapamil Hydrochloride for Chronic Rhinosinusitis With Nasal Polyps
- Lead sponsor
- Benjamin Bleier
- Phase
- Phase 1
- Overall status
- Terminated
- Start date
- June 5, 2017
- Completion date
- March 26, 2018
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.